Silymarin combined with edible traditional Chinese medicine alleviates chronic inflammation by modulating gut microbiota-mediated bile acid metabolism in patients with metabolic dysfunction-associated fatty liver disease: A randomized controlled trial

View at publisher
Authors: Zhixin Li, Shan Wang, Di Wang, Ya Wang, Meiqing Mai, Yongdui Ruan, Bingquan Mo, Zhongxia Li, Honghui Guo
Cited by: 1
References: 51

Fields of Study & Subjects

Silymarin and Mushroom Poisoning Berberine and alkaloids research Liver Disease Diagnosis and Treatment

Publication details

Journal / source
PharmaNutrition
Publisher
Elsevier BV
Volume
36
Pages
100504–100504
Publication date
16 May 2026
Language
EN